SCHEMBL30422841

SCHEMBL30422841

[2H]c1cnc(N2CCNCC2)nc1-c1ccccn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ HTR7 P34969 2/20 0.52
▸ HTR1A P08908 1/20 0.49
▸ PLD1 Q13393 1/20 0.49
▸ ADRB1 P08588 1/20 0.46
▸ ACHE P22303 3/20 0.45
▸ HTR2C P28335 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ SLC6A4 P31645 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ PIM1 P11309 1/20 0.40
▸ PIM3 Q86V86 1/20 0.40
▸ FLT3 P36888 1/20 0.40
▸ TYRO3 Q06418 1/20 0.40
▸ MERTK Q12866 1/20 0.40
▸ GAS6 Q14393 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9069333 0.78 HTR7 (0.59) KDM4EALDH1A1HTR7HTR1APLD1
SCHEMBL9690192 0.74 HTR7 (0.65) KDM4EALDH1A1HTR7HTR1APLD1
SCHEMBL2225874 0.74 KMT2A (0.57) KDM4EALDH1A1HTR7HTR1AADRB1
SCHEMBL10974393 0.73 KMT2A (0.60) KDM4EALDH1A1HTR7HTR1APLD1
SCHEMBL9073239 0.73 HTR7 (0.54) KDM4EALDH1A1HTR7HTR1APLD1
2-Piperazin-1-Yl-Pyrimidine SCHEMBL893739 0.73 ALDH1A1 (0.95) KDM4EALDH1A1HTR7PLD1ADRB1
2-Piperazin-1-Yl-Pyrimidine SCHEMBL169214 0.73 ALDH1A1 (0.95) KDM4EALDH1A1HTR7PLD1ADRB1
Hydrochloric Acid SCHEMBL3272283 0.72 ALDH1A1 (0.57) KDM4EALDH1A1HTR7HTR1AADRB1
Hydrochloric Acid SCHEMBL11161534 0.72 KMT2A (0.58) KDM4EALDH1A1HTR7HTR1AADRB1
2-Piperazin-1-Yl-Pyrimidine SCHEMBL101561 0.71 ALDH1A1 (1.00) KDM4EALDH1A1HTR7PLD1ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4441042-A1 5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND METHODS OF USING THE SAME Rgenta Therapeutics, Inc. (US) 2024-10-09 — — EP disclosed
WO-2023102231-A1 5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND METHODS OF USING THE SAME RGENTA THERAPEUTICS, INC. (US) 2023-06-08 — — WO disclosed
Send feedback